# Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea-hypopnoea syndrome.

> PubMed lists PMID 25455831 in Diabetes & metabolism as Case Reports, Letter, with publication-date metadata of 2014-11-06 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-25455831-liraglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2015-11-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25455831-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-25455831-liraglutide-v1.json
- Content SHA-256: `7fff9c5aae7c863fa29abca1d2df4d457ec3d8da7f44cd0fb8791e5f9a52a9bf`

## Claims and source pins

### Headline

Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea-hypopnoea syndrome. ([`pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8`](#source-pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8))

### Summary

PubMed lists PMID 25455831 in Diabetes & metabolism as Case Reports, Letter, with publication-date metadata of 2014-11-06 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8`](#source-pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8))

### Paragraph 1

PubMed lists PMID 25455831 in Diabetes & metabolism as Case Reports, Letter, with publication-date metadata of 2014-11-06 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8`](#source-pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8`](#source-pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8))

## Sources

<a id="source-pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8"></a>
- **Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea-hypopnoea syndrome. · retained source version 1:2015-11-19:current:8d002470f2a8ce9e677961788c4b1e6340884c480f8b2ef6c6564e45ed2f6ffa** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25455831/) (`pubmed-observation-pmid-25455831-2015-11-19-8d002470f2a8`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea-hypopnoea syndrome." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-25455831-liraglutide-v1.json SHA-256: 7fff9c5aae7c863fa29abca1d2df4d457ec3d8da7f44cd0fb8791e5f9a52a9bf.